Ticagrelor plus aspirin reduced stroke risk by 27% in patients with heart plaque: Study Hina Zahid21 Nov 2020 10:30 AM ISTDALLAS - Patients with plaque build-up in their arteries, who suffered a transient ischemic attack (TIA) or a minor ischemic stroke, also called a...
Lesser risk of recurrent MI with prasugrel than ticagrelor in STEMI patients: Circulation Medha Baranwal17 Nov 2020 2:15 PM ISTGermany: The use of ticagrelor versus prasugrel in STEMI patients undergoing primary PCI did not lead to significant differences in incidence of...
Tricaglor not linked to better outcomes in ACS after PCI compared to clopiogril: JAMA Medha Baranwal2 Nov 2020 9:15 AM ISTUSA: The use of ticagrelor over clopidogrel, in ACS patients treated with PCI do not lead to better clinical outcomes, suggests a recent study in...
Ticagrelor ups death and bleeding risk in elderly MI patients: SWEDEHEART Registry Medha Baranwal3 Sept 2020 10:00 AM ISTStockholm, Sweden: The use of ticagrelor versus clopidogrel in elderly myocardial infarction (MI) patients increases the risk of death and bleeding,...
Aspirin ticagrelor combo reduces stroke, death risk in TIA patients: NEJM Medha Baranwal22 July 2020 8:00 PM ISTUSA: Ticagrelor-aspirin versus aspirin alone reduced the risk of the composite of stroke or death within 30 days in patients with mild-to-moderate...
Ticagrelor treatment decreases osteoarthritis risk, finds new study Medha Baranwal22 July 2020 7:00 PM ISTUSA: A five-year-long study found ticagrelor treatment to be associated with a 29% lower risk of developing osteoarthritis (OA) compared to...
Safety of bioabsorbable polymer against durable polymer DES in high-risk PCI patients Hina Zahid16 May 2020 9:30 AM ISTWASHINGTON - The researchers conducted a novel study to find whether drug-eluting stents (DES) coated with bioabsorbable polymer (BP) presented a...
Ticagrelor alone good enough 3 months after stenting, finds TWILIGHT subanalysis Dr. Kamal Kant Kohli1 April 2020 4:45 PM ISTTWILIGHT subanalysis finds that 3 months after stenting ticagrelor alone was beneficial for subgroup of high-risk patients.
Does ticagrelor lower the risk of MACE in patients of ACS undergoing PCI? Dr. K B Aarthi7 March 2020 10:30 AM ISTOne year after PCI, patients taking ticagrelor had similar rates of MACE and faced greater safety risks.
